Celldex Therapeutics (CLDX) Gains from Investment Securities (2017 - 2018)
Celldex Therapeutics' (CLDX) quarterly Gains from Investment Securities came in at $26.8 million in Q4 2018, up 22242.98% year-on-year from N/an in Q4 2017, and up 486.34% quarter-over-quarter from -$6.9 million in Q3 2018.
Celldex Therapeutics (CLDX) Gains from Investment Securities (2017 - 2018) Analysis & Trends
Celldex Therapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $26.8 million for Q4 2018.
- On a quarterly basis, Gains from Investment Securities rose 22242.98% year-over-year to $26.8 million in Q4 2018; TTM through Dec 2018 was -$1.2 million, a 266.04% decrease from a year earlier, with the FY2023 full-year figure at -$1.1 million, down 109.89% from the prior year.
- Gains from Investment Securities improved to $26.8 million in Q4 2018 per CLDX's latest filing, from -$6.9 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $26.8 million in Q4 2018 and bottomed at -$13.6 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 26.79 Mn |
| Dec 31, 2018 | 26.79 Mn |
| Sep 30, 2018 | -6.94 Mn |
| Sep 30, 2018 | -6.94 Mn |
| Jun 30, 2018 | -7.43 Mn |
| Jun 30, 2018 | -7.43 Mn |
| Mar 31, 2018 | -13.60 Mn |
| Mar 31, 2018 | -13.60 Mn |
| Dec 31, 2017 | -121,000.00 |
| Dec 31, 2017 | -121,000.00 |
| Sep 30, 2017 | -4.60 Mn |
| Sep 30, 2017 | -4.60 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Mar 31, 2017 | 3.40 Mn |
| Mar 31, 2017 | 3.40 Mn |